Hillsdale Investment Management Inc. Bioventus Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.79 Billion
- Q4 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 28,092 shares of BVS stock, worth $271,087. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,092
Previous 31,192
9.94%
Holding current value
$271,087
Previous $372,000
20.97%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding BVS
# of Institutions
158Shares Held
45.3MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$126 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$67 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$38.9 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$23.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$22.9 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $595M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...